A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a certain combination of anti-HIV drugs is safe and
effective in HIV-infected patients. The drug combination includes a tablet containing
lamivudine and zidovudine (called Combivir) plus abacavir plus efavirenz.
Phase:
Phase 4
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir Dideoxynucleosides Efavirenz Lamivudine Lamivudine, zidovudine drug combination Zidovudine